Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DORIA

Showing results (301-310 of 667) with videos related to

Pageof 67
Sort By:
Current Pharmaceutical Biotechnology|December 9, 2014
Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with β-cyclodextrinPaula dos P Menezes, Adriano A de S Araujo, Grace Anne A Doria, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Plos One|April 18, 2019
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boostingCheng Cheng, Kai Xu, Rui Kong, et al.
Nature Communications|November 21, 2023
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide siteBailey B Banach, Sergei Pletnev, Adam S Olia, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Plos Pathogens|January 5, 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingNicole A Doria-Rose, Han R Altae-Tran, Ryan S Roark, et al.
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Journal of Virology|April 17, 2020
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited ResponsesGwo-Yu Chuang, Yen-Ting Lai, Jeffrey C Boyington, et al.
Pageof 67

Showing results (301-310 of 667) with videos related to

Sort By:
Pageof 67
Current Pharmaceutical Biotechnology|December 9, 2014
Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with β-cyclodextrinPaula dos P Menezes, Adriano A de S Araujo, Grace Anne A Doria, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Plos One|April 18, 2019
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boostingCheng Cheng, Kai Xu, Rui Kong, et al.
Nature Communications|November 21, 2023
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide siteBailey B Banach, Sergei Pletnev, Adam S Olia, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Plos Pathogens|January 5, 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingNicole A Doria-Rose, Han R Altae-Tran, Ryan S Roark, et al.
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Lupus|February 14, 2009
European consensus statement on the terminology used in the management of lupus glomerulonephritisC Gordon, D Jayne, C Pusey, et al.
Journal of Virology|April 17, 2020
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited ResponsesGwo-Yu Chuang, Yen-Ting Lai, Jeffrey C Boyington, et al.
Pageof 67